サイト内検索


登録済み会員ログイン




未登録の方はこちらから登録できます。
新規会員登録


ご利用案内

ご利用案内


連絡先

TEL.03-5812-5270
FAX.03-3831-0495
E-mail:info@spi-information.com


関連サイト・サービス

市場調査のご依頼、専門分野のイベント・フォーラムの開催などは シード・プランニングにて承っております。

シードプランニング

世界の医療・医薬品産業レポートのデータベースサービスは、sekairyo.comにてご利用いただけます。

sekairyo.com

医療従事者へのあらゆる形態の調査は、メドサークルにお任せ下さい。

メドサークル


セキュリティについて

当サイトのコンテンツ利用時に送信される機密情報は、Verisign認証の元暗号化されて送信されます。


CRO Regulatory Services for Generics and Biosimilars Drugs Market Report 2020-2030

ジェネリックおよびバイオシミラー医薬品のCRO規制関連サービス市場レポート2020−2030

レポート概要

サービス別予測(規制関連書類作成、出版、臨床試験の申請および製品登録、規制関連コンサルティング、法的代理人、その他の規制関連サービス分析)、用途別(オンコロジー、心臓内科、感染症、代謝疾患、その他)、臨床フェーズ別(前臨床、第I相、第II相、第III相、第IV相)、エンドユース別(製薬企業、バイテク企業、政府機関、その他)、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東、アフリカ)、プラスCOVID-19の影響シナリオ、主要CRO規制サービス企業のプロフィール

ジェネリックおよびバイオシミラー医薬品のCRO規制関連サービスー動向、研究開発の進歩、売上予測
ジェネリックおよびバイオシミラー医薬品のCRO規制関連サービス市場はどこへ向かっているのでしょうか。Visiongainのレポートはデータ、動向、事業機会、事業見通しについて評価、分析を行い、2030年までに予想される収益の流れを示します。

トップの座を維持するために
580ページを超えるレポートには500以上の表とグラフが掲載されています。読み進めるうちにこの業種で最も有望な分野と市場の将来見通しが明らかになります。世界市場全体と地域別に売上予測を示します。ジェネリックおよびバイオシミラー医薬品のCRO規制関連サービス市場にはまだ多くのビジネスチャンスが残っています。

レポート詳細

目次

1. Report Overview
1.1 Overview of CRO Regulatory Services for Generics and Biosimilars Drugs: R&D, Industry and Market
1.2 Why You Should Read this Report
1.3 How This Study Delivers
1.4 Main Questions Answered by the Analysis
1.5 Who is This Investigation For?
1.6 Method of Research and Analysis
1.7 Recovery Scenarios
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2. Executive Summary
2.1 Key Market Facts: CRO Regulatory Services for Generics and Biosimilars Drugs 2019-2030
2.2 Geographical Scenario
2.3 Companies in the Market

3. Introduction to CRO Regulatory Services for Generics and Biosimilars Drugs
3.1 What are Contract Research Organizations (CROs)
3.2 CRO Services
3.2.1 Medical Function
3.2.2 Regulatory Application Team
3.2.3 Clinical Operations
3.2.4 Data management:
3.2.5 Biostatistics
3.2.6 Medical Writing
3.2.7 Quality Assurance
3.3 Importance of Outsourcing CRO Services

4. CRO Regulatory Services for Generics and Biosimilar Drugs: Qualitative Analysis 2020-2030
4.1 Market Drivers Analysis: 2020-2030
4.1.1 Growing Demand for Contract Manufacturing Services
4.1.2 Focus On Core Competencies By Pharmaceutical and Biopharmaceutical Companies
4.1.3 Rise in Demand for Biosimilars and Generics
4.2 Market Restraints Analysis: 2020-2030
4.2.1 Project Delays and Cancellations
4.2.2 Shortage of Skilled Professionals
4.3 Market Opportunities Analysis: 2020-2030
4.3.1 Favourable Shift of Regulatory Landscape
4.3.2 Pricing Pressures and Intense Competition Among Pharmaceutical and Biopharmaceutical Companies
4.3.3 CROs in Emerging Market
4.4 Market Trends: 2020-2030
4.4.1 Advantages of Outsourcing
4.4.2 Growing Trend to Outsource the Regulatory Affairs

5. CRO Regulatory Services Industry Study, 2020-2030
5.1 CRO Regulatory Services Industry: Porters Five Forces Analysis, 2020-2030
5.1.1 Bargaining Power of Supplier: Low
5.1.2 Bargaining Power of Buyer: Moderate
5.1.3 Competitive Rivalry: High
5.1.4 Threat of New Entrants: Moderate
5.1.5 Threat of Substitutes: Low
5.2 SWOT Analysis
5.2.1 Strengths
5.2.1.1 Outsourcing Improves Time to Launch Product in the Market
5.2.1.2 Global Demand for Affordable Biopharmaceuticals has Never Been Greater
5.2.1.3 Adoption of Biosimilar will be Proportional to the Rate of Discount
5.2.1.4 Approval Pathways are Now Established in Developed Markets
5.2.1.5 Manufacturers Get Access to Specialised Technologies
5.2.1.6 Shift Towards Emerging Markets as Favourable Outsourcing Destinations
5.2.2 Weaknesses
5.2.2.1 Complexity of Protein Molecules Leads to Technical Challenges
5.2.2.2 Doctor and Patient Confidence May Take Time
5.2.3 Opportunities
5.2.3.1 Dynamic Change: Emerging Markets are Major Biosimilar Developers
5.2.3.2 Market Opportunities from Patent Expiries and a Well-stocked Pipeline
5.2.3.3 Many Companies Cannot Afford In-house Capabilities
5.2.3.4 Changing World Demographics
5.2.4 Threats
5.2.4.1 Biobetters Offer a Serious Threat to the Production and Uptake of Biosimilars
5.3 Regulatory Framework Analysis
5.4 PEST Analysis: CRO Regulatory Services for Generics and Biosimilars Drugs Market 2020-2030
5.4.1 Political Issues: Stringent Regulations Hurdles to Market Entry
5.4.2 Economic Pressures Raise Demand for Generic and Biosimilar Drugs
5.4.2.1 Fragmentation of the Market Could Limit Individual Revenues
5.4.3 Social Factors: Driving or Restraining the Market?
5.4.4 Technological Factors Concentrate on Reducing Costs and Increasing Ease of Production

6. CRO Regulatory Services for Generics and Biosimilars Drugs Market: Impact of COVID-19

7. Global CRO Regulatory Services for Generics and Biosimilar Drugs Market Landscape 2020-2030
7.1 Global CRO Regulatory Services for Generics and Biosimilar Drugs Market
7.1.1 Global CRO Regulatory Services for Generics and Biosimilar Drugs Market: Recovery Scenarios (V, U, W, L)
7.2 Market Share Analysis By Services
7.3 Market Share Analysis By Region 2020-2030

8. CRO Regulatory Services for Generics and Biosimilar Drugs Market by Services, 2020-2030
8.1 Market Overview
8.2 CRO Regulatory Services for Generics and Biosimilar Drugs Market by Services, Market Forecast 2020-2030
8.2.1 Recovery Scenarios (V, U, W, L): CRO Regulatory Services for Generics and Biosimilar Drugs Market by Services, 2020-2030
8.3 Market Share of CRO Regulatory Services for Generics and Biosimilar Drugs
8.3.1 Regulatory Writing and Publishing
8.3.2 Clinical Trial Application and Product Registration
8.3.3 Regulatory Consulting
8.3.4 Legal Representation
8.3.5 Other Regulatory Affairs

9. CRO Regulatory Services for Generics and Biosimilar Drugs Market by Application, 2020-2030
9.1 Market Overview
9.2 Market Forecast 2020-2030
9.2.1 Recovery Scenarios (V, U, W, L): CRO Regulatory Services for Generics and Biosimilar Drugs Market by Application, 2020-2030
9.3 Market Share of CRO Regulatory Services for Generics and Biosimilar Drugs
9.3.1 Oncology
9.3.2 Cardiology
9.3.3 Infectious Diseases
9.3.4 Metabolic Disorders
9.3.5 Other Applications

10. CRO Regulatory Services for Generics and Biosimilar Drugs Market by Clinical Phase, 2020-2030
10.1 Market Overview
10.2 Market Forecast 2020-2030
10.2.1 Recovery Scenarios (V, U, W, L): CRO Regulatory Services for Generics and Biosimilar Drugs Market by Clinical Phase, 2020-2030
10.3 Market Share of CRO Regulatory Services for Generics and Biosimilar Drugs
10.3.1 Pre-clinical Phase
10.3.2 Phase I
10.3.3 Phase II
10.3.4 Phase III
10.3.5 Phase IV

11. CRO Regulatory Services for Generics and Biosimilar Drugs Market by End User, 2020-2030
11.1 Market Overview
11.2 Market Forecast 2020-2030
11.2.1 Recovery Scenarios (V, U, W, L): CRO Regulatory Services for Generics and Biosimilar Drugs Market by End Use, 2020-2030
11.3 Market Share of CRO Regulatory Services for Generics and Biosimilar Drugs
11.3.1 Pharmaceutical Companies
11.3.2 Biotechnology Companies
11.3.3 Government Institutes
11.3.4 Others

12. Leading National Markets 2020-2030
12.1 Geographical Breakdown of the World CRO Regulatory Services for Generics and Biosimilars Drugs Market
12.2 Global CRO Regulatory Services for Generics and Biosimilars Drugs Market: Regional Forecast 2020-2030
12.3 How Will Regional Market Shares Change by 2030?

13. North America CRO Regulatory Services for Generics and Biosimilars Drugs Market, 2020-2030
13.1 North America CRO Regulatory Services for Generics and Biosimilar Drugs Market by Service, 2020 to 2030
13.1.1 Recovery Scenarios (V, U, W, L): North America CRO Regulatory Services for Generics and Biosimilar Drugs Market by Service, 2020 to 2030
13.2 North America CRO Regulatory Services for Generics and Biosimilar Drugs Market by Application, 2020 to 2030
13.2.1 Recovery Scenarios (V,U,W,L): North America CRO Regulatory Services for Generics and Biosimilar Drugs Market by Application, 2020 to 2030
13.3 North America CRO Regulatory Services for Generics and Biosimilar Drugs Market by Clinical Phase, 2020 to 2030
13.3.1 Recovery (V,U,W,L) Scenarios: North America CRO Regulatory Services for Generics and Biosimilar Drugs Market by Clinical Phase, 2020 to 2030
13.4 North America CRO Regulatory Services for Generics and Biosimilar Drugs Market by End-Use, 2020 to 2030
13.4.1 Recovery (V,U,W,L) Scenarios: North America CRO Regulatory Services for Generics and Biosimilar Drugs Market by End-Use, 2020 to 2030
13.5 North America CRO Regulatory Services for Generics and Biosimilar Drugs Market: Recovery Scenarios (V, U, W, L)
13.6 US CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast 2020-2030
13.6.1 U.S. CRO Regulatory Services for Generics and Biosimilar Drugs Market: Recovery Scenarios (V, U, W, L)
13.7 Canada CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast 2020-2030
13.7.1 Canada CRO Regulatory Services for Generics and Biosimilar Drugs Market: Recovery Scenarios (V, U, W, L)

14. Europe CRO Regulatory Services for Generics and Biosimilars Drugs Market, 2020-2030
14.1 Europe CRO Regulatory Services for Generics and Biosimilar Drugs Market by Service, 2020 to 2030
14.1.1 Recovery Scenarios (V, U, W, L): Europe CRO Regulatory Services for Generics and Biosimilar Drugs Market by Service, 2020 to 2030
14.2 Europe CRO Regulatory Services for Generics and Biosimilar Drugs Market by Application, 2020 to 2030
14.2.1 Recovery Scenarios (V,U,W,L): Europe CRO Regulatory Services for Generics and Biosimilar Drugs Market by Application, 2020 to 2030
14.3 Europe CRO Regulatory Services for Generics and Biosimilar Drugs Market by Clinical Phase, 2020 to 2030
14.3.1 Recovery (V,U,W,L) Scenarios: Europe CRO Regulatory Services for Generics and Biosimilar Drugs Market by Clinical Phase, 2020 to 2030
14.4 Europe CRO Regulatory Services for Generics and Biosimilar Drugs Market by End-Use, 2020 to 2030
14.4.1 Recovery (V,U,W,L) Scenarios: Europe CRO Regulatory Services for Generics and Biosimilar Drugs Market by End-Use, 2020 to 2030
14.5 Europe CRO Regulatory Services for Generics and Biosimilar Drugs Market: Recovery Scenarios (V, U, W, L)
14.6 Germany CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast 2020-2030
14.6.1 Germany CRO Regulatory Services for Generics and Biosimilar Drugs Market: Recovery Scenarios (V, U, W, L)
14.7 UK CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast 2020-2030
14.7.1 UK CRO Regulatory Services for Generics and Biosimilar Drugs Market: Recovery Scenarios (V, U, W, L)
14.8 French CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast 2020-2030
14.8.1 French CRO Regulatory Services for Generics and Biosimilar Drugs Market: Recovery Scenarios (V, U, W, L)
14.9 Italian CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast 2020-2030
14.9.1 Italian CRO Regulatory Services for Generics and Biosimilar Drugs Market: Recovery Scenarios (V, U, W, L)
14.10 Spanish CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast 2020-2030
14.10.1 Spanish CRO Regulatory Services for Generics and Biosimilar Drugs Market: Recovery Scenarios (V, U, W, L)
14.11 Russia CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast 2020-2030
14.11.1 Russian CRO Regulatory Services for Generics and Biosimilar Drugs Market: Recovery Scenarios (V, U, W, L)
14.12 Rest of Europe CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast 2020-2030
14.12.1 Rest of Europe CRO Regulatory Services for Generics and Biosimilar Drugs Market: Recovery Scenarios (V, U, W, L)

15. Asia Pacific CRO Regulatory Services for Generics and Biosimilars Drugs Market 2020-2030
15.1 Asia Pacific CRO Regulatory Services for Generics and Biosimilar Drugs Market by Service, 2020 to 2030
15.1.1 Recovery Scenarios (V, U, W, L): Asia Pacific CRO Regulatory Services for Generics and Biosimilar Drugs Market by Service, 2020 to 2030
15.2 Asia Pacific CRO Regulatory Services for Generics and Biosimilar Drugs Market by Application, 2020 to 2030
15.2.1 Recovery Scenarios (V,U,W,L): Asia Pacific CRO Regulatory Services for Generics and Biosimilar Drugs Market by Application, 2020 to 2030
15.3 Asia Pacific CRO Regulatory Services for Generics and Biosimilar Drugs Market by Clinical Phase, 2020 to 2030
15.3.1 Recovery (V,U,W,L) Scenarios: Asia Pacific CRO Regulatory Services for Generics and Biosimilar Drugs Market by Clinical Phase, 2020 to 2030
15.4 Asia Pacific CRO Regulatory Services for Generics and Biosimilar Drugs Market by End-Use, 2020 to 2030
15.4.1 Recovery (V,U,W,L) Scenarios: Asia Pacific CRO Regulatory Services for Generics and Biosimilar Drugs Market by End-Use, 2020 to 2030
15.5 Asia Pacific CRO Regulatory Services for Generics and Biosimilar Drugs Market: Recovery Scenarios (V, U, W, L)
15.6 Japanese CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast 2020-2030
15.6.1 Japanese CRO Regulatory Services for Generics and Biosimilar Drugs Market: Recovery Scenarios (V, U, W, L)
15.7 Chinese CRO Regulatory Services for Generics and Biosimilars Drugs Market 2020-2030
15.7.1 Chinese CRO Regulatory Services for Generics and Biosimilar Drugs Market: Recovery Scenarios (V, U, W, L)
15.8 Indian CRO Regulatory Services for Generics and Biosimilars Drugs Market 2020-2030
15.8.1 Indian CRO Regulatory Services for Generics and Biosimilar Drugs Market: Recovery Scenarios (V, U, W, L)
15.9 Australia CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast 2020-2030
15.9.1 Australia CRO Regulatory Services for Generics and Biosimilar Drugs Market: Recovery Scenarios (V, U, W, L)
15.10 Rest of Asia Pacific CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast 2020-2030
15.10.1 Rest of Asia Pacific CRO Regulatory Services for Generics and Biosimilar Drugs Market: Recovery Scenarios (V, U, W, L)

16. Latin America CRO Regulatory Services for Generics and Biosimilars Drugs Market 2020-2030
16.1 Latin America CRO Regulatory Services for Generics and Biosimilar Drugs Market by Service, 2020 to 2030
16.1.1 Recovery Scenarios (V, U, W, L): Latin America CRO Regulatory Services for Generics and Biosimilar Drugs Market by Service, 2020 to 2030
16.2 Latin America CRO Regulatory Services for Generics and Biosimilar Drugs Market by Application, 2020 to 2030
16.2.1 Recovery Scenarios (V,U,W,L): Latin America CRO Regulatory Services for Generics and Biosimilar Drugs Market by Application, 2020 to 2030
16.3 Latin America CRO Regulatory Services for Generics and Biosimilar Drugs Market by Clinical Phase, 2020 to 2030
16.3.1 Recovery (V,U,W,L) Scenarios: Latin America CRO Regulatory Services for Generics and Biosimilar Drugs Market by Clinical Phase, 2020 to 2030
16.4 Latin America CRO Regulatory Services for Generics and Biosimilar Drugs Market by End-Use, 2020 to 2030
16.4.1 Recovery (V,U,W,L) Scenarios: Latin America CRO Regulatory Services for Generics and Biosimilar Drugs Market by End-Use, 2020 to 2030
16.5 Latin America CRO Regulatory Services for Generics and Biosimilar Drugs Market: Recovery Scenarios (V, U, W, L)
16.6 Brazilian CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast 2020-2030
16.6.1 Brazilian CRO Regulatory Services for Generics and Biosimilar Drugs Market: Recovery Scenarios (V, U, W, L)
16.7 Mexico CRO Regulatory Services for Generics and Biosimilars Drugs Market 2020-2030
16.7.1 Mexican CRO Regulatory Services for Generics and Biosimilar Drugs Market: Recovery Scenarios (V, U, W, L)
16.8 Rest of Latin America CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast 2020-2030
16.8.1 Rest of Latin America CRO Regulatory Services for Generics and Biosimilar Drugs Market: Recovery Scenarios (V, U, W, L)

17. MEA CRO Regulatory Services for Generics and Biosimilars Drugs Market 2020-2030
17.1 MEA CRO Regulatory Services for Generics and Biosimilar Drugs Market by Service, 2020 to 2030
17.1.1 Recovery Scenarios (V, U, W, L): MEA CRO Regulatory Services for Generics and Biosimilar Drugs Market by Service, 2020 to 2030
17.2 MEA CRO Regulatory Services for Generics and Biosimilar Drugs Market by Application, 2020 to 2030
17.2.1 Recovery Scenarios (V,U,W,L): MEA CRO Regulatory Services for Generics and Biosimilar Drugs Market by Application, 2020 to 2030
17.3 MEA CRO Regulatory Services for Generics and Biosimilar Drugs Market by Clinical Phase, 2020 to 2030
17.3.1 Recovery (V,U,W,L) Scenarios: MEA CRO Regulatory Services for Generics and Biosimilar Drugs Market by Clinical Phase, 2020 to 2030
17.4 MEA CRO Regulatory Services for Generics and Biosimilar Drugs Market by End-Use, 2020 to 2030
17.4.1 Recovery (V,U,W,L) Scenarios: MEA CRO Regulatory Services for Generics and Biosimilar Drugs Market by End-Use, 2020 to 2030
17.5 MEA CRO Regulatory Services for Generics and Biosimilar Drugs Market: Recovery Scenarios (V, U, W, L)
17.6 GCC CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast 2020-2030
17.6.1 GCC CRO Regulatory Services for Generics and Biosimilar Drugs Market: Recovery Scenarios (V, U, W, L)
17.7 South Africa CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast 2020-2030
17.7.1 South Africa CRO Regulatory Services for Generics and Biosimilar Drugs Market: Recovery Scenarios (V, U, W, L)
17.8 Rest of MEA CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast 2020-2030
17.8.1 Rest of MEA CRO Regulatory Services for Generics and Biosimilar Drugs Market: Recovery Scenarios (V, U, W, L)

18. Leading Companies in the CRO Regulatory Services for Generics and Biosimilars Drugs Market
18.1 IQVIA
18.1.1 IQVIA: Company Snapshot
18.1.2 IQVIA: Company Overview
18.1.3 IQVIA: Financials, 2015-2019
18.1.4 IQVIA: Services
18.1.5 IQVIA: Recent Developments
18.2 ICON plc.
18.2.1 ICON plc.: Company Snapshot
18.2.2 ICON plc.: Company Overview
18.2.3 ICON plc.: Financial Overview 2015-2019
18.2.4 ICON plc.: Services Portfolio
18.2.5 ICON plc.: Recent Developments
18.3 Pharmaceutical Product Development (PPD)
18.3.1 Pharmaceutical Product Development (PPD): Company Snapshot
18.3.2 Pharmaceutical Product Development (PPD): Company Overview
18.3.3 Pharmaceutical Product Development (PPD): Services Portfolio
18.3.4 Pharmaceutical Product Development (PPD): Recent Developments
18.4 Covance Inc.
18.4.1 Covance Inc.: Company Snapshot
18.4.2 Covance Inc.: Company Overview
18.4.3 Covance Inc.: Financial Overview
18.4.4 Covance Inc.: Services Portfolio
18.4.5 Covance Inc.: Recent Developments
18.5 Genpact Ltd.
18.5.1 Genpact Ltd.: Company Snapshot
18.5.2 Genpact Ltd.: Company Overview
18.5.3 Genpact Ltd.: Financial Overview
18.5.4 Genpact Ltd.: Services Portfolio
18.5.5 Genpact Ltd.: Recent Developments
18.6 Criterium Inc.
18.6.1 Criterium Inc.: Company Snapshot
18.6.2 Criterium Inc.: Company Overview
18.6.3 Criterium Inc.: Services Portfolio
18.6.4 Criterium Inc.: Recent Developments
18.7 Accell Clinical Research, LLC
18.7.1 Accell Clinical Research, LLC: Company Snapshot
18.7.2 Accell Clinical Research, LLC: Company Overview
18.7.3 Accell Clinical Research, LLC: Services Portfolio
18.7.4 Accell Clinical Research, LLC: Recent Developments
18.8 Charles River Laboratories International
18.8.1 Charles River Laboratories: Company Snapshot
18.8.2 Charles River Laboratories: Company Overview
18.8.3 Charles River Laboratories: Financial Overview
18.8.4 Charles River Laboratories: Services
18.8.5 Charles River Laboratories: Recent Developments
18.9 Medpace, Inc.
18.9.1 Medpace Inc.: Company Snapshot
18.9.2 Medpace Inc.: Company Overview
18.9.3 Medpace Inc.: Financial Overview
18.9.4 Medpace Inc.: Services Portfolio
18.9.5 Medpace Inc.: Recent Developments
18.10 WuXi AppTec
18.10.1 WuXi AppTec: Company Snapshot
18.10.2 WuXi AppTec: Company Overview
18.10.3 WuXi AppTec: Financial Overview
18.10.4 WuXi AppTec: Services Portfolio
18.10.5 WuXi AppTec: Recent Developments
18.11 Syneos Health
18.11.1 Syneos Health: Company Snapshot
18.11.2 Syneos Health: Company Overview
18.11.3 Syneos Health: Financial Overview
18.11.4 Syneos Health: Services Portfolio
18.11.5 Syneos Health: Recent Developments

19. Conclusions
19.1 CRO Regulatory Services for Generics and Biosimilars Drugs: Global Market, 2020-2030
19.2 Leading National Markets for CRO Regulatory Services for Generics and Biosimilars Drugs2020-2030
19.3 Leading Companies in the CRO Regulatory Services for Generics and Biosimilars Drugs Market

20. Associated Visiongain Reports

List of Figures
Figure 1 CRO Regulatory Services For Generics And Biosimilars Drugs Segmentation By Service, 2019
Figure 2 Global CRO Regulatory Services for Generics and Biosimilar Drugs Market Overview
Figure 3 Porter’s Five Forces Analysis
Figure 4 Porter’s Five Force Analysis of the CRO Regulatory Services for Generics and Biosimilar Drugs Market, 2019
Figure 5 SWOT Analysis
Figure 6 PEST Analysis
Figure 7 Global CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 8 “V” Shaped Recovery: Global CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 9 “U” Shaped Recovery: Global CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 10 “W” Shaped Recovery: Global CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 11 “L” Shaped Recovery: Global CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 12 Global CRO Regulatory Services for Generics and Biosimilar Drugs Market Share(%), By Service 2020, 2025, & 2030
Figure 13 Global CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Share(%), By Region 2020, 2025, & 2030
Figure 14 Global CRO Regulatory Services for Generics and Biosimilars Drugs Market, By Services: Revenues (%), 2020, 2025, & 2030
Figure 15 Global Regulatory Writing and Publishing Market Forecast: Revenue ($bn) and AGR (%), 2019-2030
Figure 16 “V” Shaped Recovery: Global Regulatory Writing and Publishing Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 17 “U” Shaped Recovery: Global Regulatory Writing and Publishing Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 18 “W” Shaped Recovery: Global Regulatory Writing and Publishing Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 19 “L” Shaped Recovery: Global Regulatory Writing and Publishing Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 20 Global Clinical Trial Application and Product Registration Market Forecast: Revenue ($bn) and AGR (%), 2019-2030
Figure 21 “V” Shaped Recovery: Global Clinical Trial Application and Product Registration Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 22 “U” Shaped Recovery: Global Clinical Trial Application and Product Registration Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 23 “W” Shaped Recovery: Global Clinical Trial Application and Product Registration Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 24 “L” Shaped Recovery: Global Clinical Trial Application and Product Registration Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 25 Global Regulatory Consulting Market Forecast: Revenue ($bn) and AGR (%), 2019-2030
Figure 26 “V” Shaped Recovery: Global Regulatory Consulting Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 27 “U” Shaped Recovery: Global Regulatory Consulting Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 28 “W” Shaped Recovery: Global Regulatory Consulting Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 29 “L” Shaped Recovery: Global Regulatory Consulting Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 30 Global Legal Representation Market Forecast: Revenue ($bn) and AGR (%), 2019-2030
Figure 31 “V” Shaped Recovery: Global Legal Representation Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 32 “U” Shaped Recovery: Global Legal Representation Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 33 “W” Shaped Recovery: Global Legal Representation Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 34 “L” Shaped Recovery: Global Legal Representation Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 35 Global Other Regulatory Affairs Market Forecast: Revenue ($bn) and AGR (%), 2019-2030
Figure 36 “V” Shaped Recovery: Global Other Regulatory Affairs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 37 “U” Shaped Recovery: Global Other Regulatory Affairs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 38 “W” Shaped Recovery: Global Other Regulatory Affairs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 39 “L” Shaped Recovery: Global Other Regulatory Affairs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 40 Global CRO Regulatory Services for Generics and Biosimilars Drugs Market, By Application: Revenues (%), 2020, 2025, & 2030
Figure 41 Oncology Market Forecast: Revenue ($bn) and AGR (%), 2019-2030
Figure 42 “V” Shaped Recovery: Global Oncology Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 43 “U” Shaped Recovery: Global Oncology Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 44 “W” Shaped Recovery: Global Oncology Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 45 “L” Shaped Recovery: Global Oncology Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 46 Global Cardiology Market Forecast: Revenue ($bn) and AGR (%), 2019-2030
Figure 47 “V” Shaped Recovery: Global Cardiology Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 48 “U” Shaped Recovery: Global Cardiology Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 49 “W” Shaped Recovery: Global Cardiology Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 50 “L” Shaped Recovery: Global Cardiology Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 51 Global Regulatory Consulting Market Forecast: Revenue ($bn) and AGR (%), 2019-2030
Figure 52 “V” Shaped Recovery: Global Infectious Diseases Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 53 “U” Shaped Recovery: Global Infectious Diseases Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 54 “W” Shaped Recovery: Global Infectious Diseases Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 55 “L” Shaped Recovery: Global Infectious Diseases Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 56 Global Metabolic Disorders Market Forecast: Revenue ($bn) and AGR (%), 2019-2030
Figure 57 “V” Shaped Recovery: Global Metabolic Disorders Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 58 “U” Shaped Recovery: Global Metabolic Disorders Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 59 “W” Shaped Recovery: Global Metabolic Disorders Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 60 “L” Shaped Recovery: Global Metabolic Disorders Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 61 Global Other Applications Market Forecast: Revenue ($bn) and AGR (%), 2019-2030
Figure 62 “V” Shaped Recovery: Global Other Applications Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 63 “U” Shaped Recovery: Global Other Applications Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 64 “W” Shaped Recovery: Global Other Applications Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 65 “L” Shaped Recovery: Global Other Applications Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 66 Global CRO Regulatory Services for Generics and Biosimilars Drugs Market, By Clinical Phase: Revenues (%), 2020, 2025, & 2030
Figure 67 Global Preclinical Phase Market Forecast: Revenue ($bn) and AGR (%), 2019-2030
Figure 68 “V” Shaped Recovery: Global Pre-clinical Phase Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 69 “U” Shaped Recovery: Global Pre-clinical Phase Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 70 “W” Shaped Recovery: Global Pre-clinical Phase Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 71 “L” Shaped Recovery: Global Pre-clinical Phase Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 72 Global Phase I Market Forecast: Revenue ($bn) and AGR (%), 2019-2030
Figure 73 “V” Shaped Recovery: Global Phase I Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 74 “U” Shaped Recovery: Global Phase I Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 75 “W” Shaped Recovery: Global Phase I Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 76 “L” Shaped Recovery: Global Phase I Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 77 Global Phase II Market Forecast: Revenue ($bn) and AGR (%), 2019-2030
Figure 78 “V” Shaped Recovery: Global Phase II Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 79 “U” Shaped Recovery: Global Phase II Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 80 “W” Shaped Recovery: Global Phase II Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 81 “L” Shaped Recovery: Global Phase II Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 82 Global Phase III Market Forecast: Revenue ($bn) and AGR (%), 2019-2030
Figure 83 “V” Shaped Recovery: Global Phase III Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 84 “U” Shaped Recovery: Global Phase III Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 85 “W” Shaped Recovery: Global Phase III Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 86 “L” Shaped Recovery: Global Phase III Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 87 Global Phase IV Market Forecast: Revenue ($bn) and AGR (%), 2019-2030
Figure 88 “V” Shaped Recovery: Global Phase IV Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 89 “U” Shaped Recovery: Global Phase IV Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 90 “W” Shaped Recovery: Global Phase IV Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 91 “L” Shaped Recovery: Global Phase IV Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 92 Global CRO Regulatory Services for Generics and Biosimilars Drugs Market, By End Use: Revenues (%), 2020, 2025, & 2030
Figure 93 Global Pharmaceutical Companies Market Forecast: Revenue ($bn) and AGR (%), 2019-2030
Figure 94 “V” Shaped Recovery: Global Pharmaceutical Companies Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 95 “U” Shaped Recovery: Global Pharmaceutical Companies Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 96 “W” Shaped Recovery: Global Pharmaceutical Companies Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 97 “L” Shaped Recovery: Global Pharmaceutical Companies Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 98 Global Biotechnology Companies Market Forecast: Revenue ($bn) and AGR (%), 2019-2030
Figure 99 “V” Shaped Recovery: Global Biotechnology Companies Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 100 “U” Shaped Recovery: Global Biotechnology Companies Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 101 “W” Shaped Recovery: Global Biotechnology Companies Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 102 “L” Shaped Recovery: Global Biotechnology Companies Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 103 Global Government Institutes Market Forecast: Revenue ($bn) and AGR (%), 2019-2030
Figure 104 “V” Shaped Recovery: Global Government Institutes Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 105 “U” Shaped Recovery: Global Government Institutes Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 106 “W” Shaped Recovery: Global Government Institutes Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 107 “L” Shaped Recovery: Global Government Institutes Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 108 Global Others Market Forecast: Revenue ($bn) and AGR (%), 2019-2030
Figure 109 “V” Shaped Recovery: Global Others Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 110 “U” Shaped Recovery: Global Others Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 111 “W” Shaped Recovery: Global Others Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 112 “L” Shaped Recovery: Global Others Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 113 Global CRO Regulatory Services for Generics and Biosimilars Drugs Market, By Region: Revenues (%), 2020, 2025, & 2030
Figure 114 North America CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast: Revenue ($bn) and AGR (%), 2020-2030
Figure 115 North America CRO Regulatory Services for Generics and Biosimilars Drugs Market, By Region Forecast: Market Share 2020, 2025, & 2030
Figure 116 “V” Shaped Recovery: North America CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 117 “U” Shaped Recovery: North America CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 118 “W” Shaped Recovery: North America CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 119 “L” Shaped Recovery: North America CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 120 US CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast: Revenue ($bn) and AGR (%), 2020-2030
Figure 121 “V” Shaped Recovery: U.S. CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 122 “U” Shaped Recovery: U.S. CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 123 “W” Shaped Recovery: U.S. CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 124 “L” Shaped Recovery: U.S. CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 125 Canada CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast: Revenue ($bn) and AGR (%), 2020-2030
Figure 126 “V” Shaped Recovery: Canada CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 127 “U” Shaped Recovery: Canada CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 128 “W” Shaped Recovery: Canada CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 129 “L” Shaped Recovery: Canada CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 130 Europe CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast: Revenue ($bn) and AGR (%), 2020-2030
Figure 131 Europe CRO Regulatory Services for Generics and Biosimilars Drugs Market, By Country: Revenue (%), 2020, 2025, & 2030
Figure 132 “V” Shaped Recovery: Europe CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 133 “U” Shaped Recovery: Europe CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 134 “W” Shaped Recovery: Europe CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 135 “L” Shaped Recovery: Europe CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 136 Germany CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast: Revenue ($bn) and AGR (%), 2020-2030
Figure 137 “V” Shaped Recovery: Germany CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 138 “U” Shaped Recovery: Germany CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 139 “W” Shaped Recovery: Germany CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 140 “L” Shaped Recovery: Germany CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 141 UK CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast: Revenue ($bn) and AGR (%), 2020-2030
Figure 142 “V” Shaped Recovery: UK CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 143 “U” Shaped Recovery: UK CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 144 “W” Shaped Recovery: UK CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 145 “L” Shaped Recovery: UK CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 146 French CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast: Revenue ($bn) and AGR (%), 2020-2030
Figure 147 “V” Shaped Recovery: French CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 148 “U” Shaped Recovery: French CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 149 “W” Shaped Recovery: French CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 150 “L” Shaped Recovery: French CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 151 Italian CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast: Revenue ($bn) and AGR (%), 2020-2030
Figure 152 “V” Shaped Recovery: Italian CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 153 “U” Shaped Recovery: Italian CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 154 “W” Shaped Recovery: Italian CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 155 “L” Shaped Recovery: Italian CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 156 Spanish CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast: Revenue ($bn) and AGR (%), 2020-2030
Figure 157 “V” Shaped Recovery: Spanish CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 158 “U” Shaped Recovery: Spanish CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 159 “W” Shaped Recovery: Spanish CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 160 “L” Shaped Recovery: Spanish CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 161 Russia CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast: Revenue ($bn) and AGR (%), 2020-2030
Figure 162 “V” Shaped Recovery: Russian CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 163 “U” Shaped Recovery: Russian CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 164 “W” Shaped Recovery: Russian CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 165 “L” Shaped Recovery: Russian CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 166 Rest of Europe CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast: Revenue ($bn) and AGR (%), 2020-2030
Figure 167 “V” Shaped Recovery: Rest of Europe CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 168 “U” Shaped Recovery: Rest of Europe CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 169 “W” Shaped Recovery: Rest of Europe CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 170 “L” Shaped Recovery: Rest of Europe CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 171 Asia Pacific CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast: Revenue ($bn) and AGR (%), 2020-2030
Figure 172 Asia Pacific CRO Regulatory Services for Generics and Biosimilars Drugs Market, By Country: Revenue (%), 2020, 2025, & 2030
Figure 173 “V” Shaped Recovery: Asia Pacific CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 174 “U” Shaped Recovery: Asia Pacific CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 175 “W” Shaped Recovery: Asia Pacific CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 176 “L” Shaped Recovery: Asia Pacific CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 177 Japanese CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast: Revenue ($bn) and AGR (%), 2020-2030
Figure 178 “V” Shaped Recovery: Japanese CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 179 “U” Shaped Recovery: Japanese CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 180 “W” Shaped Recovery: Japanese CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 181 “L” Shaped Recovery: Japanese CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 182 Chinese CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast: Revenue ($bn) and AGR (%), 2020-2030
Figure 183 “V” Shaped Recovery: Chinese CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 184 “U” Shaped Recovery: Chinese CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 185 “W” Shaped Recovery: Chinese CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 186 “L” Shaped Recovery: Chinese CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 187 Indian CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast: Revenue ($bn) and AGR (%), 2020-2030
Figure 188 “V” Shaped Recovery: Indian CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 189 “U” Shaped Recovery: Indian CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 190 “W” Shaped Recovery: Indian CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 191 “L” Shaped Recovery: Indian CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 192 Australia CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast: Revenue ($bn) and AGR (%), 2020-2030
Figure 193 “V” Shaped Recovery: Australia CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 194 “U” Shaped Recovery: Australia CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 195 “W” Shaped Recovery: Australia CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 196 “L” Shaped Recovery: Australia CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 197 Rest of Asia Pacific CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast: Revenue ($bn) and AGR (%), 2020-2030
Figure 198 “V” Shaped Recovery: Rest of Asia Pacific CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 199 “U” Shaped Recovery: Rest of Asia Pacific CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 200 “W” Shaped Recovery: Rest of Asia Pacific CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 201 “L” Shaped Recovery: Rest of Asia Pacific CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 202 Latin America CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast: Revenue ($bn) and AGR (%), 2020-2030
Figure 203 Latin America CRO Regulatory Services for Generics and Biosimilars Drugs Market, By Country: Revenue (%), 2020, 2025, & 2030
Figure 204 “V” Shaped Recovery: Latin America CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 205 “U” Shaped Recovery: Latin America CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 206 “W” Shaped Recovery: Latin America CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 207 “L” Shaped Recovery: Latin America CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 208 Brazilian CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast: Revenue ($bn) and AGR (%), 2020-2030
Figure 209 “V” Shaped Recovery: Brazilian CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 210 “U” Shaped Recovery: Brazilian CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 211 “W” Shaped Recovery: Brazilian CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 212 “L” Shaped Recovery: Brazilian CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 213 Mexico CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast: Revenue ($bn) and AGR (%), 2020-2030
Figure 214 “V” Shaped Recovery: Mexican CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 215 “U” Shaped Recovery: Mexican CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 216 “W” Shaped Recovery: Mexican CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 217 “L” Shaped Recovery: Mexican CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 218 Rest of Latin America CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast: Revenue ($bn) and AGR (%), 2020-2030
Figure 219 “V” Shaped Recovery: Rest of Latin America CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 220 “U” Shaped Recovery: Rest of Latin America CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 221 “W” Shaped Recovery: Rest of Latin America CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 222 “L” Shaped Recovery: Rest of Latin America CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 223 MEA CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast: Revenue ($bn) and AGR (%), 2020-2030
Figure 224 MEA CRO Regulatory Services for Generics and Biosimilars Drugs Market, By Country: Revenue (%), 2020-2030
Figure 225 “V” Shaped Recovery: MEA CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 226 “U” Shaped Recovery: MEA CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 227 “W” Shaped Recovery: MEA CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 228 “L” Shaped Recovery: MEA CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 229 GCC CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast: Revenue ($bn) and AGR (%), 2020-2030
Figure 230 “V” Shaped Recovery: GCC CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 231 “U” Shaped Recovery: GCC CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 232 “W” Shaped Recovery: GCC CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 233 “L” Shaped Recovery: GCC CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 234 South Africa CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast: Revenue ($bn) and AGR (%), 2020-2030
Figure 235 “V” Shaped Recovery: South Africa CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 236 “U” Shaped Recovery: South Africa CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 237 “W” Shaped Recovery: South Africa CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 238 “L” Shaped Recovery: South Africa CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 239 Rest of MEA CRO Regulatory Services for Generics and Biosimilars Drugs Market Forecast: Revenue ($bn) and AGR (%), 2020-2030
Figure 240 “V” Shaped Recovery: Rest of MEA CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 241 “U” Shaped Recovery: Rest of MEA CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 242 “W” Shaped Recovery: Rest of MEA CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 243 “L” Shaped Recovery: Rest of MEA CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%) 2020-2030
Figure 244 IQVIA: Revenue ($mn), 2015-2019
Figure 245 IQVIA: Segment Revenue ($mn), 2017-2019
Figure 246 IQVIA: Regional Revenue ($mn), 2017-2019
Figure 247 ICON plc.: Financial Overview, 2015-2019
Figure 248 ICON plc.: Regional Revenue Share, 2019
Figure 249 Covance Drug Development (CDD): Financial Overview, 2017-2019
Figure 250 Genpact Ltd.: Financial Overview, 2017-2019
Figure 251 Genpact Ltd.: Client Business Overview, 2019
Figure 252 Charles River Laboratories International: Financial Overview, 2017-2019
Figure 253 Charles River Laboratories International: Business Overview (Revenue Share %), 2019
Figure 254 Medpace, Inc.: Financial Overview, 2017-2019
Figure 255 Medpace, Inc.: Business Overview (Revenue Share, %), 2019
Figure 256 WuXi AppTec: Financial Overview, 2017-2019
Figure 257 Syneos Health: Financial Overview, 2017-2019
Figure 258 CRO Regulatory Services for Generics and Biosimilars Drugs Market By Services: Comparison of Revenues ($m), 2019, 2025 and 2030
Figure 259 Leading National Markets: Revenues ($m), 2019, 2025 and 2030

List of Tables
Table 1 Global CRO Regulatory Services for Generics and Biosimilar Drugs Market, 2020-2030 (US$ million, CAGR %)
Table 2 World CRO Regulatory Services for Generics and Biosimilars Drugs Market, By Region: Revenue ($Bn) and Market Share (%) 2019 and 2030
Table 3 Global CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 4 “V” Shaped Recovery: Global CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 5 “U” Shaped Recovery: Global CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 6 “W” Shaped Recovery: Global CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 7 “L” Shaped Recovery: Global CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 8 World CRO Regulatory Services for Generics and Biosimilars Drugs Market, By Service: Revenue ($Bn) and Market Share (%) 2019 and 2030
Table 9 World CRO Regulatory Services for Generics and Biosimilars Drugs Market, By Region: Revenue ($Bn) and Market Share (%) 2019 and 2030
Table 10 Global CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 11 “V” Shaped Recovery: Global CRO Regulatory Services for Generics and Biosimilar Drugs Market by Services, Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 12 “U” Shaped Recovery: Global CRO Regulatory Services for Generics and Biosimilar Drugs Market by Services, Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 13 “L” Shaped Recovery: Global CRO Regulatory Services for Generics and Biosimilar Drugs Market by Services, Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 14 “W” Shaped Recovery: Global CRO Regulatory Services for Generics and Biosimilar Drugs Market by Services, Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 15 Global Regulatory Writing and Publishing Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2020-2030
Table 16 “V” Shaped Recovery: Global Regulatory Writing and Publishing Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 17 “U” Shaped Recovery: Global Regulatory Writing and Publishing Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 18 “W” Shaped Recovery: Global Regulatory Writing and Publishing Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 19 “L” Shaped Recovery: Global Regulatory Writing and Publishing Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 20 Global Clinical Trial Application and Product Registration Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2020-2030
Table 21 “V” Shaped Recovery: Global Clinical Trial Application and Product Registration Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 22 “U” Shaped Recovery: Global Clinical Trial Application and Product Registration Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 23 “W” Shaped Recovery: Global Clinical Trial Application and Product Registration Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 24 “L” Shaped Recovery: Global Clinical Trial Application and Product Registration Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 25 Global Regulatory Consulting Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2020-2030
Table 26 “V” Shaped Recovery: Global Regulatory Consulting Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 27 “U” Shaped Recovery: Global Regulatory Consulting Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 28 “W” Shaped Recovery: Global Regulatory Consulting Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 29 “L” Shaped Recovery: Global Regulatory Consulting Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 30 Global Legal Representation Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2020-2030
Table 31 “V” Shaped Recovery: Global Legal Representation Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 32 “U” Shaped Recovery: Global Legal Representation Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 33 “W” Shaped Recovery: Global Legal Representation Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 34 “L” Shaped Recovery: Global Legal Representation Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 35 Global Other Regulatory Affairs Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2020-2030
Table 36 “V” Shaped Recovery: Global Other Regulatory Affairs Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 37 “U” Shaped Recovery: Global Other Regulatory Affairs Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 38 “W” Shaped Recovery: Global Other Regulatory Affairs Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 39 “L” Shaped Recovery: Global Other Regulatory Affairs Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 40 Global CRO Regulatory Services for Generics and Biosimilar Drugs Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 41 “V” Shaped Recovery: Global CRO Regulatory Services for Generics and Biosimilar Drugs Market by Application Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 42 “U” Shaped Recovery: Global CRO Regulatory Services for Generics and Biosimilar Drugs Market by Application Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 43 “L” Shaped Recovery: Global CRO Regulatory Services for Generics and Biosimilar Drugs Market by Application Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 44 “W” Shaped Recovery: Global CRO Regulatory Services for Generics and Biosimilar Drugs Market by Application Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 45 Oncology Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2020-2030
Table 46 “V” Shaped Recovery: Global Oncology Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 47 “U” Shaped Recovery: Global Oncology Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 48 “W” Shaped Recovery: Global Oncology Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 49 “L” Shaped Recovery: Global Oncology Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 50 Global Cardiology Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2020-2030
Table 51 “V” Shaped Recovery: Global Cardiology Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 52 “U” Shaped Recovery: Global Cardiology Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 53 “W” Shaped Recovery: Global Cardiology Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 54 “L” Shaped Recovery: Global Cardiology Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 55 Global Infectious Diseases Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2020-2030
Table 56 “V” Shaped Recovery: Global Infectious Diseases Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 57 “U” Shaped Recovery: Global Infectious Diseases Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 58 “W” Shaped Recovery: Global Infectious Diseases Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 59 “L” Shaped Recovery: Global Infectious Diseases Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 60 Global Metabolic Disorders Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2020-2030
Table 61 “V” Shaped Recovery: Global Metabolic Disorders Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 62 “U” Shaped Recovery: Global Metabolic Disorders Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 63 “W” Shaped Recovery: Global Metabolic Disorders Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 64 “L” Shaped Recovery: Global Metabolic Disorders Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 65 Global Other Applications Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2020-2030
Table 66 “V” Shaped Recovery: Global Other Applications Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2020-2030
Table 67 “U” Shaped Recovery:

発刊日

2020/08/10

体裁

PDF / 506ページ

販売価格

3,999GBP

発行

Visiongain

備考

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※販売価格はシングルユーザーライセンスのものとなります。
※シングルユーザーライセンスのレポートは印刷不可、およびライセンス期間は1年となります。
※印刷可能のレポートをご希望の場合は、デパートメントライセンス(ライセンス期間1年、ユーザー数5人)をご検討ください。
※詳しくはお問い合わせください。

関連カテゴリ

医薬品原料・製剤 / アウトソーシング

購入・お問い合わせ

このレポートを購入

詳細を問い合わせる


PAGE